|
Volumn 17, Issue 6, 2011, Pages
|
Comparative effectiveness research in inflammatory bowel disease
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
CERTOLIZUMAB PEGOL;
INFLIXIMAB;
NATALIZUMAB;
COMPARATIVE EFFECTIVENESS;
COST EFFECTIVENESS ANALYSIS;
CROHN DISEASE;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HUMAN;
LETTER;
PATIENT SAFETY;
PRIORITY JOURNAL;
COMPARATIVE EFFECTIVENESS RESEARCH;
DRUG INDUSTRY;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH SUPPORT AS TOPIC;
|
EID: 79955851406
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1002/ibd.21693 Document Type: Letter |
Times cited : (1)
|
References (21)
|